definiens: means recombinant Protective Antigen ( rPA ) vaccine against anthrax ; means any contract entered into by a member of the Vendors ’ Groupduring the Restricted Period with a third party not being a member of the Purchaser ’s Group for the manufacture ofany vaccine against pneumonic or bubonic plague ( other than the Plague Vaccine ) in the ABC5000 plant at theBillingham Site ( or any alternative site or sites having a similar aggregate scale ) ; means net sales of one or more vaccines against pneumonic or bubonicplague other than the Plague Vaccine made by any member of the Vendors ’ Group in respect of each and any PlagueSmall Scale Contract and/or Plague Manufacturing Contract, where such net sales shall be calculated as the grossamount billed by any member of the Vendors ’ Group less the following ( i ) customary trade, quantity or cashdiscounts to the extent actually allowed and taken ; ( ii ) amounts repaid or credited by reason of rejection or return;(iii ) to the extent separately stated on purchase order, invoices or other documents of sale, any taxes or othergovernmental charges levied on the production, sale, transportation, delivery or use of any products or servicesdelivered under the relevant Plague Small Scale Contract and/or Plague Manufacturing Contract which is paid by oron behalf of any member of the Vendors ’ Group ; ( iv ) outbound transportation costs prepaid or allowed and 2 costs of insurance in transit, in each case in respect of deliveries outside the UK ; ( vi ) costs of delivery devices ordelivery systems used for dispensing or administering product ; and ( vii ) deductions for premiums for governmentmandated insurance ; provided however that Plague Manufacturing Net Sales shall ( a ) be calculated after addition ordeduction ( as appropriate ) of any true - up adjustments made either to or by any member of the Vendors ’ Group and(b ) include any royalties paid to any member of the Vendors ’ Group on account of any Plague ManufacturingContract in respect of any technology relating to any vaccine against pneumonic or bubonic plague ; means any contract entered into by a member of the Vendors ’ Group duringthe Restricted Period with a third party not being a member of the Purchaser ’s Group for the process developmentand / or scale - up for or in connection with the possible or proposed manufacture of any vaccine against pneumonic orbubonic plague ( other than the Plague Vaccine ) and/or the manufacture of such vaccine other than in the ABC5000plant at the Billingham Site ( or any alternative site or sites having a similar aggregate scale ) ; means Yersinia pestis Antigen ( rYP ) vaccine ( comprising rF1 and rV recombinant antigensin non - fused form ) against pneumonic or bubonic plague ( and for the avoidance of doubt a vaccine comprising rF1and rV recombinant antigens in fused form is not a ) ; ”